Inoue M, Morikawa M, Tsuboi M, Yamada T, Sugiura M
Jpn J Pharmacol. 1979 Feb;29(1):17-25. doi: 10.1254/jjp.29.17.
Esterase from human intestinal mucosa was purified 210 fold by solubilization with Triton X-100, chromatography on DEAE-cellulose, Sephadex G-100 and hydroxylapatite, and isoelectric focusing. The purified esterase showed a single band by polyacrylamide gel electrophoresis. The molecular weight of the purified esterase was estimated to be about 55,000 by gel filtration on Sephadex G-150, and the isoelectric point was 5.02. The purified esterase was strongly inhibited by diethyl p-nitrophenyl phosphate (E-600) and diisopropyl fluorophosphate (DFP), and was not inhibited by eserine sulfate and p-chloromercuribenzoate. The purified esterase from human intestinal mucosa was found to be one of the carboxylesterases. The purified esterase hydrolyzed ester-type drugs, i.e., aspirin, clofibrate, indanyl carbenicillin and procaine, but did not hydrolyze amide-type drugs and choline-type drugs.
通过用Triton X - 100溶解、在DEAE - 纤维素、Sephadex G - 100和羟基磷灰石上进行色谱分离以及等电聚焦,人肠黏膜酯酶被纯化了210倍。纯化后的酯酶在聚丙烯酰胺凝胶电泳中显示为单一条带。通过在Sephadex G - 150上进行凝胶过滤,估计纯化酯酶的分子量约为55,000,其等电点为5.02。纯化后的酯酶受到对硝基苯基磷酸二乙酯(E - 600)和二异丙基氟磷酸酯(DFP)的强烈抑制,但不受硫酸依色林和对氯汞苯甲酸的抑制。发现人肠黏膜纯化酯酶是羧酸酯酶之一。纯化后的酯酶可水解酯型药物,即阿司匹林、氯贝丁酯、茚满青霉素和普鲁卡因,但不水解酰胺型药物和胆碱型药物。